Dieckol, an edible seaweed polyphenol, retards rotenone-induced neurotoxicity and α-synuclein aggregation in human dopaminergic neuronal cells-Reference-Cited by-同舟云学术

Dieckol, an edible seaweed polyphenol, retards rotenone-induced neurotoxicity and α-synuclein aggregation in human dopaminergic neuronal cells

Published:2016 Issue:111 Volume:6 Page:110040-110046
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Cha Seon-Heui¹²³⁴⁵,Heo Soo-Jin⁶⁷⁸⁴,Jeon You-Jin⁹¹⁰⁸⁴,Park Sang Myun¹²³⁴⁵^ORCID

Affiliation:

1. Department of Pharmacology

2. Ajou University School of Medicine

3. Suwon

4. Korea

5. Chronic Inflammatory Disease Research Center

6. Jeju International Marine Science Center for Research & Education

7. Korea Institute of Ocean Science & Technology (KIOST)

8. Jeju

9. School of Marine Biomedical Sciences

10. Jeju National University

Abstract

Dopaminergic neurons are particularly vulnerable to oxidative stress, which may initiate a cascade of intracellular toxic events that lead to protein aggregation and subsequent cell death, causing Parkinson's disease.

Funder

Ministry of Science, ICT and Future Planning

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2016/RA/C6RA21697H

Reference56 articles.

1. Parkinson's disease

2. Epigallocatechin Gallate (EGCG) Inhibits Alpha-Synuclein Aggregation: A Potential Agent for Parkinson’s Disease

3. Mitochondrial dysfunction in Parkinson's disease

4. Role of Oxidative Stress in Parkinson's Disease

5. The Role of Oxidative Stress in Parkinson's Disease

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allelochemicals from the seaweeds and their bioprospecting potential;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-02-23

2. Recent advances in natural products targeting α-synuclein aggregation or clearance in Parkinson's disease;European Journal of Medicinal Chemistry Reports;2023-12

3. Research Progress of α-Synuclein Aggregation Inhibitors for Potential Parkinson’s Disease Treatment;Mini-Reviews in Medicinal Chemistry;2023-11

4. Marine-Derived Components: Can They Be a Potential Therapeutic Approach to Parkinson’s Disease?;Marine Drugs;2023-08-16

5. Therapeutic effects of phlorotannins in the treatment of neurodegenerative disorders;Frontiers in Molecular Neuroscience;2023-05-18